Logo
Euro Gen MGF, 5mg

Euro Gen MGF, 5mg

Euro-Gen

Peptides
  • Supplier states UK Based manufacturing with minimum peptide purity greater than 99% confirmed by third Party analytical testing.
  • Manufactured and distributed under a research Use Only framework; not authorised as a medicinal product under MHRA or EMA regulations.
  • Intended to comply with general laboratory chemical and research reagent standards, rather than medical device or medicinal product regulations.
Research peptide \u2013 Mechano Growth Factor (MGF)

Description

Euro-Gen MGF, 5mg is a UK-manufactured research-grade peptide containing Mechano Growth Factor (MGF), a splice variant of insulin-like growth factor-1 (IGF-1) associated in preclinical studies with skeletal muscle repair, tissue regeneration, and related cellular pathways. It is supplied as a 5 mg vial in the peptide category and is explicitly marketed for in vitro and laboratory research use only, not for human or veterinary administration.

Bnefits

  • Provides a defined research-grade source of Mechano Growth Factor (MGF), an IGF-1 splice variant implicated in muscle repair and tissue regeneration pathways in preclinical models.
  • Supplied as a 5 mg vial suitable for controlled laboratory experiments and in vitro mechanistic studies.
  • Produced under a UK-based brand that states minimum peptide purity >99% with third-party testing for composition and purity.
  • Offered with detailed storage guidance for lyophilised and reconstituted peptides to help maintain stability during research use.
  • Clearly labelled as a research-use-only reagent, helping to distinguish it from licensed medicinal products.

Indications

  • In vitro and laboratory research into Mechano Growth Factor (MGF) biology, including its role as an IGF-1 splice variant.
  • Preclinical research on skeletal muscle repair, regeneration, and satellite cell activation pathways.
  • Experimental studies on tissue repair, cartilage and bone biology, and neurobiological roles of MGF in non-clinical models.
  • Method development and assay validation involving MGF in cell culture, biochemical, or molecular biology experiments.
  • General educational and exploratory research on growth factor signalling, not involving administration to humans or animals.

Composition

  • Active component: Synthetic Mechano Growth Factor (MGF) peptide, 5 mg per vial (exact amino acid sequence and excipients not specified by the seller).

Formulation

  • Lyophilised (powder) peptide supplied for reconstitution prior to use in laboratory experiments.
  • Packaged as a 5 mg unit dose intended for in vitro and other non-clinical research applications.
  • No bacteriostatic water or diluent included; solvent must be supplied separately by the researcher.

Packaging

  • Single 5 mg research peptide unit (vial) listed under the Peptides category.
  • Sterile, sealed container suitable for cold-chain storage; detailed secondary packaging description not provided by the seller.
  • Sold individually via online peptide and aesthetic-product retailers.

Usage

  • For laboratory and in vitro research use only; not for human or veterinary use, injection, ingestion, or topical application.
  • Reconstitute the lyophilised peptide with an appropriate sterile solvent (e.g., bacteriostatic or sterile water for injection, as determined by institutional protocols) under aseptic conditions.
  • Mix gently after reconstitution and avoid excessive agitation that could denature the peptide.
  • Use reconstituted solutions promptly and store according to institutional peptide-handling SOPs; the seller does not provide dosage or administration guidance due to its research-only status.
  • Handle only by trained, qualified personnel in an appropriate laboratory environment, following local regulations and safety guidelines.
  • Dispose of any unused material and waste in accordance with institutional biosafety and chemical waste procedures.

Contraindications

  • Not to be used in humans or animals (no injection, ingestion, inhalation, or topical application).
  • Not indicated for therapeutic, cosmetic, or diagnostic use in any clinical setting.
  • Should not be used outside appropriately equipped research laboratories by untrained personnel.
  • Use is contraindicated in any context that would contravene local laws or regulations regarding unlicensed medicinal products or research chemicals.

Adverse Effects

  • No clinically characterised adverse-effect profile, as the product is not intended or licensed for administration to humans or animals.
  • Any potential toxicological or off-target effects must be evaluated within controlled experimental systems and must not be assumed to predict human safety.
  • Handling-related risks (e.g., accidental exposure, laboratory contamination) should be managed via standard laboratory safety protocols, including PPE use.

Storage Conditions

  • Lyophilised (powder) peptides should be stored at approximately -20°C to -80°C in a dry, dark environment for long-term stability.
  • After reconstitution, store at about 4°C and use within a few weeks as per institutional SOPs; avoid repeated freeze–thaw cycles.
  • Keep vials tightly capped, protected from light and moisture at all times.
  • Once the cap has been removed and the vial opened, immediate use is recommended and storage after opening is discouraged by the supplier.

Duration

Not applicable \u2013 Euro-Gen MGF, 5mg is a research-use-only peptide with no established or authorised clinical treatment duration.

Onset

Not applicable \u2013 no onset-of-effect data in humans; available information relates only to preclinical and in vitro models and must not be extrapolated to clinical use.

Browse more Peptides

Top Treatments

Top Cities in the UK